uFraction8 Secures £3.4m in Seed Funding

Deal News | Feb 24, 2025 | Foresight Group

Pioneering continuous bio-separation technology company, uFraction8, has successfully completed a £3.4m seed funding round. The round was spearheaded by Foresight Group’s Ventures team, showcasing the growing interest and investment in innovative biotech solutions. Other key investors included Old College Capital, Scottish Enterprise, Alwyn Capital and existing investors such as Thia Ventures. The funds are expected to propel uFraction8's development and deployment of cutting-edge bio-separation technologies crucial for various biomanufacturing industries.

Sectors

  • Biotechnology
  • Venture Capital

Geography

  • United Kingdom – uFraction8 and several of the investors, including Scottish Enterprise and Old College Capital, are based in the UK, making it the primary geography of focus.

Industry

  • Biotechnology – uFraction8 operates in the biotechnology sector with its focus on bio-separation technology, a critical component of biomanufacturing.
  • Venture Capital – The funding round was led by Foresight Group, a venture capital firm, indicating the sector's vibrant role in financing biotech innovations.

Financials

  • £3.4m – Total seed funding amount raised by uFraction8.

Participants

NameRoleTypeDescription
uFraction8Target companyCompanyA company specializing in continuous bio-separation technology.
Foresight GroupLead investorCompanyA venture capital firm that led the funding round.
Old College CapitalInvestorCompanyInvestment arm of the University of Edinburgh, providing funding to promising ventures.
Scottish EnterpriseInvestorGovernmentScotland’s national economic development agency, involved in supporting innovative startups.
Alwyn CapitalInvestorCompanyAn investment firm participating in the uFraction8 funding round.
Thia VenturesExisting investorCompanyA venture capital firm that previously invested in uFraction8.